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REST/NRSF (repressor-element-1-silencing transcription factor/
neuron-restrictive silencing factor) negatively regulates the tran-
scription of genes containing RE1 sites1,2. REST is expressed in
non-neuronal cells and stem/progenitor neuronal cells, in which
it inhibits the expression of neuron-specific genes. Overexpression
of REST is frequently found in human medulloblastomas and
neuroblastomas3–7, in which it is thought to maintain the stem
character of tumour cells. Neural stem cells forced to express
REST and c-Myc fail to differentiate and give rise to tumours in
the mouse cerebellum3. Expression of a splice variant of REST that
lacks the carboxy terminus has been associated with neuronal
tumours and small-cell lung carcinomas8–10, and a frameshift
mutant (REST-FS), which is also truncated at the C terminus,
has oncogenic properties11. Here we show, by using an unbiased
screen, that REST is an interactor of the F-box protein b-TrCP.
REST is degraded by means of the ubiquitin ligase SCFb-TrCP dur-
ing the G2 phase of the cell cycle to allow transcriptional derepres-
sion of Mad2, an essential component of the spindle assembly
checkpoint. The expression in cultured cells of a stable REST
mutant, which is unable to bind b-TrCP, inhibited Mad2 expres-
sion and resulted in a phenotype analogous to that observed in
Mad21/2 cells. In particular, we observed defects that were con-
sistent with faulty activation of the spindle checkpoint, such as
shortened mitosis, premature sister-chromatid separation, chro-
mosome bridges and mis-segregation in anaphase, tetraploidy,
and faster mitotic slippage in the presence of a spindle inhibitor.
An indistinguishable phenotype was observed by expressing the
oncogenic REST-FS mutant11, which does not bind b-TrCP. Thus,
SCFb-TrCP-dependent degradation of REST during G2 permits the
optimal activation of the spindle checkpoint, and consequently it
is required for the fidelity of mitosis. The high levels of REST or its
truncated variants found in certain human tumours may contri-
bute to cellular transformation by promoting genomic instability.
F-box proteins are the substrate-recognition subunits of SCF
(SKP1–CUL1–F-box protein) ubiquitin ligases, providing specificity
to ubiquitin conjugation reactions12,13. Mammals express two para-
logues of the F-box protein b-TrCP (b-TrCP1 and b-TrCP2) that are
biochemically indistinguishable; we shall therefore use b-TrCP to
refer to both, unless otherwise specified.
To identify substrates of the SCFb-TrCP ubiquitin ligase, we used an
immunoaffinity/enzymatic assay followed by mass spectrometry
analysis14,15. In two independent purifications, peptides correspond-
ing to REST were identified. The interaction between REST and
b-TrCP suggested that SCFb-TrCP is the ubiquitin ligase targeting
REST for degradation. To investigate the specificity of this binding,
we screened 16 F-box proteins as well as two related proteins, CDH1
and CDC20. b-TrCP1 and b-TrCP2 were the only proteins that
immunoprecipitated together with endogenous REST (Fig. 1a and
data not shown). Interaction between endogenous b-TrCP1 and
REST was also observed (Supplementary Fig. 1a).
Most proteins recognized by b-TrCP contain aDSGXXS degron in
which the serine residues are phosphorylated, allowing binding to
b-TrCP16. REST has a similar motif at the C terminus in which the
first serine residue is replaced by glutamic acid, in an analogous
manner to other known b-TrCP substrates (Supplementary Fig.
2a). Supplementary Fig. 3 shows that this sequence fits with low
energy into the three-dimensional structural space of the b-TrCP
substrate-binding surface, similarly to a phospho-peptide corres-
ponding to the degron of b-catenin, a well-characterized substrate
of b-TrCP17.
We generated a number of human REST mutants (all with hae-
magglutinin epitope (HA) tags), in which Glu 1009 and/or Ser 1013
were mutated to Ala (Supplementary Fig. 2b), expressed them in
HEK-293T cells, and immunoprecipitated them with anti-HA resin.
Whereas wild-type REST efficiently immunoprecipitated endo-
genous b-TrCP1, the REST(E1009A), REST(S1013A) and REST
(E1009A/S1013A) mutants did not (Fig. 1b and Supplementary
Fig. 1b), showing that Glu 1009 and Ser 1013 are required for binding
to b-TrCP. Accordingly, in comparison with wild-type REST, the
half-lives of REST mutants were increased in HEK-293T cells
(Fig. 1c).
Because SCFb-TrCP mediates the ubiquitination of several proteins
in specific phases of the cell cycle12,15,18–20, we analysed the expression
of REST during the cell cycle. When HeLa cells were released from a
G1/S block, REST protein levels decreased in G2, at a time when the
levels of cyclin A and Emi1, which are both degraded in early mitosis,
were still elevated (Fig. 1d). Similar oscillations in REST expression
were observed with different synchronizationmethods and cell types,
including HCT116, U-2OS and human diploid IMR-90 fibroblasts
(Supplementary Fig. 4a, b and data not shown). The proteasome
inhibitor MG132 prevented the disappearance of REST in HeLa
and HCT116 cells arrested in prometaphase by a spindle poison
(Supplementary Fig. 5a), showing that REST degradation ismediated
by the proteasome and that this degradation persists during spindle
checkpoint activation. Accordingly, in contrast with wild-type REST,
REST(E1009A/S1013A) is stable in prometaphase cells (Supplemen-
tary Fig. 6a, b).
MG132-treated prometaphase cells accumulated phosphorylated
REST (Supplementary Fig. 5b). Moreover, REST, but not REST
(E1009A/S1013A), immunopurified from prometaphase cells was
ubiquitinated in vitro in the presence of b-TrCP (but not FBXW8)
(Fig. 1e and Supplementary Fig. 5c). Finally, incubation with
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l-phosphatase completely inhibited the ubiquitination of wild-type
REST (Fig. 1e). These findings indicate that REST phosphorylation is
necessary for its ubiquitination.
To further test whether b-TrCP regulates the stability of REST,
we used a double-stranded RNA (dsRNA) oligonucleotide that
efficiently targets both b-TrCP1 and b-TrCP2 (refs 14, 15, 18) to
decrease their expression inHeLa cells. b-TrCP knockdown inhibited
the G2-specific degradation of REST (Fig. 1f).Moreover, phosphory-
lated REST accumulated after b-TrCP silencing (Supplementary
Fig. 5b).
Together, the above results demonstrate that b-TrCP-mediated
degradation of REST starts in G2, and this event requires the
DEGXXS degron in the REST C terminus.
Because REST is a transcriptional repressor, we proposed that its
degradation in G2 might be necessary to derepress genes involved in
mitosis. We therefore analysed the expression of proteins regulating
mitosis and/or cell proliferation in U-2OS cells expressing either
wild-type REST or REST(E1009A/S1013A). Prometaphase U-2OS
cells showed higher levels of REST(E1009A/S1013A) than wild-type
REST (Fig. 2a) as a result of its stabilization (SupplementaryFig. 6a, b).
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Figure 1 | REST is targeted for degradation by SCFb-TrCP duringG2. a, HEK-
293T cells were transfected with empty vector (EV) or the indicated
FLAG-tagged F-box protein constructs (FBPs). Cell extracts were
immunoprecipitated (IP) with anti-FLAG resin, and immunocomplexes
were probed for the indicated proteins. b, The indicated HA-tagged proteins
were expressed in HEK-293T cells. Cell extracts were subjected to
immunoprecipitation with anti-HA resin followed by immunoblotting. The
asterisk indicates a non-specific band. WT, wild type. c, The indicated HA-
tagged proteins were expressed inHEK-293T. At 24 h after transfection, cells
were treated with cycloheximide (CHX). Cells were collected and proteins
were analysed by immunoblotting with an anti-HA antibody (left panels) to
detect REST or with an anti-Cul1 antibody (right panels) to show loading
normalization. d, HeLa cells were synchronized by a double-thymidine block
and released into nocodazole-containingmedium. Cells were collected at the
indicated times, lysed and immunoblotted. e, b-TrCP-mediated REST
ubiquitination is dependent on phosphorylation. HeLa cells were infected
with lentiviruses expressing HA-tagged wild-type REST or HA-tagged
REST(E1009/S1013A), synchronized in prometaphase and incubated with
MG132 during the last 3 h before lysis. Cell extracts were
immunoprecipitated with anti-HA resin. Immunoprecipitates were
incubated with either l-protein phosphatase (lPPase) or enzyme buffer
before ubiquitination/degradation assays (at 30 uC for the indicated times)
in the presence of in vitro transcribed/translated b-TrCP. The bracket marks
a ladder of bands corresponding to polyubiquitinated REST detected by
immunoblotting. ex, exposure. f, HeLa cells were transfected twice with
short interfering RNA (siRNA)molecules to a non-relevant mRNA (lacZ) or
to b-TrCP mRNA and then synchronized and analysed as in d.
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Of the 37 proteins analysed, only the levels of Mad2 were altered
in cells expressing REST(E1009A/S1013A) (Fig. 2a, and data not
shown). Lower levels of Mad2 were also observed when the stable
REST mutant was expressed in IMR-90 fibroblasts (Supplementary
Fig. 7) and NIH 3T3 cells (data not shown). Mad2 is a crucial
component of the spindle checkpoint, inhibiting the anaphase-
promoting complex to prevent sister-chromatid separation until
microtubules radiating from the spindle poles have been attached
to all kinetochores21. Northern blot analysis showed downregulation
ofMad2mRNA in REST(E1009A/S1013A)-expressing cells (Fig. 2b).
Analysis of theMad2 genomic sequence showed several putative RE1
sites. Chromatin immunoprecipitation analysis confirmed in vivo
binding of endogenous REST to the Mad2 promoter (Fig. 2c). In
addition, a human Mad2 genomic fragment containing an RE1 site
(position 26–46 relative to the transcription start site), but not one
containing a deletion in the RE1 site, conferred REST responsiveness
to a luciferase reporter after the transient transfection of U-2OS or
IMR-90 cells (Fig. 2d and Supplementary Fig. 8). Dominant-negativea
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Figure 2 | Mad2 is a transcriptional target of REST. a, U-2OS cells were
infected either with an empty lentivirus (EV) or with lentiviruses expressing
HA-tagged wild-type REST or HA-tagged REST(E1009/S1013A). After
treatment with nocodazole for 15 h, mitotic cells were harvested and
analysed by immunoblotting for the indicated proteins. b,Mad2mRNAwas
assessed by northern blotting in U-2OS cells treated as in a. c, Chromatin
immunoprecipitation (ChIP) assay with an anti-REST antibody (filled
columns) in U-2OS cells. Quantitative real-time PCR amplifications were
performed with primers surrounding the RE1 site in the Mad2 promoter.
The value given for the amount of PCR product present from ChIP with
control IgG (open columns) was set as 1. GAPDH primers were used as a
negative control. d, U-2OS cells were transfected with an empty vector (EV),
HA-tagged REST proteins or a dominant-negative b-TrCP1 mutant
(FLAG–b-TrCP1 DN) together with a luciferase reporter linked to a Mad2
genomic fragment containing either a wild-type (WT) or amutated RE1 site.
Prometaphase cells were collected and the relative luciferase signal was
quantified. The value given for luciferase activity in EV-transfected cells was
set at 100%. e, IMR-90 cells were transfected twicewith siRNAmolecules to a
non-relevant mRNA (lacZ) or to REST mRNA and synchronized in G2 by
release from an aphidicolin block for the indicated durations30. Cells were
then lysed and immunoblotted. Where present, error bars represent s.d.
(n5 3).
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Figure 3 | Failure to degradeREST causesdefects in themitotic checkpoint.
a, HCT116 cells were infected either with an empty lentivirus (EV, open
columns) or with a lentivirus expressing REST(E1009/S1013A) (filled
columns). At 48 h after infection, cells were fixed and stained with 4,6-
diamidino-2-phenylindole and an anti-a-tubulin antibody to reveal DNA
and themitotic spindle, respectively. Error bars represent s.d. (n5 3).b, NIH
3T3 cells stably transfectedwith enhanced green fluorescent protein-labelled
histone H2B were infected with an empty lentivirus or with lentiviruses
expressing the indicatedHA-tagged proteins. The average time from nuclear
envelope breakdown (NEB) to anaphase onset was measured by time-lapse
microscopy. Each symbol in the scatter plot represents a single cell.
c, Representative fluorescence videomicroscopy series from b; numbers in
the top left are times (h:min).
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b-TrCP22, which stabilizes endogenous REST (data not shown),
inhibited the activity of the Mad2 promoter-driven luciferase
reporter (Fig. 2d). Importantly, depletion of REST in G2 IMR-90
cells induced an increase in Mad2 levels (Fig. 2e).
These results indicate that Mad2 is a direct and physiologically
relevant transcriptional target of REST. Consistent with this notion,
Mad2 expression (both at the mRNA and protein level) is inversely
proportional to REST protein levels during the progression of cells
through G2 (Supplementary Fig. 4b, c).
Deletion of a single Mad2 allele in mouse embryonic fibroblasts
or human HCT116 cancer cells results in a defective mitotic check-
point23. To study whether failure to degrade REST in G2 also affects
the spindle checkpoint, we analysed HCT116 cells (which have a
relatively stable karyotype) expressing HA-tagged wild-type REST
or HA-tagged REST(E1009A/S1013A). As expected, wild-type
REST was degraded in G2, whereas REST(E1009A/S1013A) was
stable in G2 (Supplementary Fig. 9). Cells expressing REST
(E1009A/S1013A) showed a decreased percentage of metaphases
(Fig. 3a). Because this effect might have been due to a faster pro-
gression through metaphase, we analysed mitotic progression by
time-lapse microscopy. The average time from nuclear envelope
breakdown to anaphase onset was decreased in cells expressing
REST(E1009A/S1013A) in comparison with control cells (Fig. 3b, c
and Supplementary Fig. 10). Moreover, expression of the stable
REST mutant increased the number of lagging chromosomes and
chromosome bridges in anaphase (Fig. 4a) and the appearance of
tetraploidy (11/61 versus 0/61 in control cells), as scored in meta-
phase spreads from two different experiments. More than 8% of cells
expressing the stable REST mutant (6/71) displayed prematurely
separated sister chromatids, in contrast with 1.4% (1/71) in control
cells (Fig. 4b). Finally, cells expressing the stable REST mutant
showed a decrease in the mitotic index in the presence of a
spindle poison, despite the fact that they entered into mitosis with
normal kinetics (Fig. 4c and Supplementary Fig. 11), suggesting an
increased rate of mitotic slippage and adaptation to the spindle
checkpoint.
These phenotypes indicate that in cells expressing the stable REST
mutant, anaphase proceeds faster and in the absence of complete and
accurate chromosome–microtubule attachment. Premature ana-
phase and chromosome aberrations are hallmarks of the defective
spindle checkpoint observed in Mad21/2 cells23.
We predicted that REST-FS, an oncogenic frame-shift mutant
from a colon cancer cell line11, would be stabilized because it lacks
the b-TrCP degron. Indeed, we found that REST-FS did not bind
b-TrCP and was stable in G2 HCT116 cells (Supplementary Figs 1b
and 12a). Expression of REST-FS in U-2OS cells caused a decrease in
Mad2 mRNA and Mad2 protein (Supplementary Fig. 12b, c) and a
decrease in the activity of a Mad2 promoter-driven luciferase
reporter (Fig. 2d), similarly to the expression of REST(E1009A/
S1013A). Finally, the mitotic phenotypes induced by the expression
of REST-FS (Figs 3b, c and 4) were indistinguishable from those
caused by REST(E1009A/S1013A).
We show here that b-TrCP-mediated degradation of REST inG2 is
necessary for the optimal expression of Mad2. Failure to degrade
REST produces a deficient spindle checkpoint and consequent chro-
mosome instability. REST is expressed in non-neuronal cells and
stem/progenitor neural cells, in which it inhibits neuronal differenti-
ation by blocking the expression of neuron-specific genes2,24. The
transition from embryonic stem cell to stem/progenitor neuronal cell
requires the proteasome-mediated degradation of REST24. Our study
suggests that REST proteolysis must be accurately controlled to avoid
subjecting neuronal tissues to cancer risk. In fact, increased levels of
REST resulting from overproduction and/or C-terminal truncations,
as observed in human neuronal tumours3–7,10, would both inhibit
differentiation and generate chromosomal instability, two mechan-
isms that contribute to tumour development. Although REST has
oncogenic properties in neuronal cells, the reduction of REST
expression in certain non-neuronal tumours suggests a tumour
suppressor role for REST and a function in the neuroendocrine
phenotype in some of these lesions11,25. C-terminally truncated
REST variants are also observed in non-neuronal tumours8–11. Our
study suggests that these stable REST variants may contribute to cell
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Figure 4 | Expression of a stable REST mutant or oncogenic REST-FS leads
to chromosomal instability. a, Left: percentage of aberrant anaphases in
HCT116 cells infected as in Fig. 3b. Right: representative pictures. Arrows
point to lagging chromosomes and chromosome bridges. b, Premature
sister-chromatid separation in cells expressing stable REST. Panels show
representative metaphase spreads in HCT116 cells infected as in Fig. 3b.
c, Nocodazole was added for the indicated durations to HCT116 cells
infected as in Fig. 3b. Cells were stained with an anti-phospho-HH3 (pHH3)
antibody to quantify theirmitotic index.Where present, error bars represent
s.d. (n5 3).
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transformation by promoting aneuploidy26 and genetic instability in
both neuronal and non-neuronal tissues.
METHODS SUMMARY
Biochemical methods. Extract preparation, immunoprecipitation and
immunoblotting were as described previously14,15,18.
Transient transfections and lentivirus-mediated gene transfer. HEK-293T
cells were transfected by using calcium phosphate. U-2OS cells were transfected
with the use of FuGENE-6 reagent (Roche). For lentivirus-mediated gene trans-
fer, HEK-293T cells were co-transfected with pTRIP-PGK together with pack-
aging vectors. At 48 h after transfection, virus-containing medium was collected
and supplemented with 8mgml21 Polybrene (Sigma). Cells were then infected
with the viral supernatant for 6 h.
Transcription analyses. RNA was extracted by using the RNeasy Kit (Qiagen).
cDNA synthesis was performed with Superscript III (Invitrogen). Quantitative
real-time PCR analysis was performed in accordance with standard procedures,
using SYBR Green mix (Bio-Rad). Mad2 primer sequences were reported pre-
viously27. Control ARPP P0 primers sequences were 59-GCACTGGAAGTC-
CAACTACTTC-39 and 59-TGAGGTCCTCCTTGGTGAACAC-39. Northern
blotting was performed as described28. 32P-labelled human full-length Mad2
complementary DNA was used as a probe to detectMad2mRNA. For luciferase
assays, U-2OS cells were transfected in a 4:2:1 ratio with HA-tagged REST con-
structs, luciferase reporter plasmid (pGL3-Mad2)27 and pCMV-b-galactosidase.
Luciferase activity was measured with the Luciferase Reporter Assay System
(Promega), and relative luciferase activities were normalized to lacZ.
Chromatin immunoprecipitations. Chromatin immunoprecipitations were
conducted as described previously29. Mad2 primer sequences were as reported
previously27. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primer
sequences were 59-TCCACCACCCTGTTGCTGTA-39 and 59-ACCACAGTCC-
ATGCCATCAC-39.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Cell culture, synchronization and drug treatments. U-2OS, HCT116, HEK-
293T, HeLa and IMR-90 cells were grown, synchronized and treated with drugs
as described previously14,15,18.
Purification of b-TrCP interactors. An immunoaffinity/enzymatic assay that
enriches for ubiquitinated substrates of F-box proteins, followed by mass spec-
trometry analysis, was described previously14,15.
Antibodies. Anti-Mad2 and anti-REST antibodies were provided by H. Yu and
by G. Mandel, respectively. Commercially available antibodies were as follows:
anti-REST-C (Upstate 07-579), anti-Mad2 (BD 610679), anti-Cul1 (Zymed 32-
2400), anti-phospho-histone H3 (anti-pHH3; Upstate 06-570), anti-M2 FLAG
(Sigma F3165), anti-Cdk1 phosphorylated on Tyr 15 (pCdk1; Santa Cruz sc-
7989-R), anti-phospho MPM2 (Upstate 05-368), and anti-a-Tubulin (Zymed
32-2500). All additional antibodies used here were described previously14,15,18.
Vectors. Human REST cDNA was provided by G. Mandel and N. Ballas
and subcloned into pcDNA3.1. REST mutants were generated using the
QuickChange Site-directed Mutagenesis kit (Stratagene). Enhanced green
fluorescent protein-labelled histone H2B cloned into pEGFP-N1 was provided
by I. Sanchez. For lentivirus production, both wild-type REST and REST
mutants were subcloned into the lentivirus vector pTRIP, which was provided
by D. Levy.
Gene silencing by small interfering RNA. siRNA for b-TrCP was described
previously14,15,18. A 21-nucleotide siRNAduplex corresponding to a non-relevant
gene (lacZ) was used as control.
Indirect immunofluorescence. Cells were plated and cultured on chambered
glass tissue-culture slides (BDFalcon)with completemedium.Cellswerewashed
in PBS, fixed and permeabilized in 100% methanol at 220 uC for 10min and
then incubated with the primary antibodies for 1 h at 25 uC in 0.5% Tween 20 in
PBS (0.5% TBST). Slides were washed three times in 0.5% TBST for 5min
and incubated with secondary antibodies diluted 1:1,000. 4,6-Diamidino-2-
phenylindole (Molecular Probes) was included to reveal nuclei. Slides were
washed in PBS and subsequently mounted with Aqua Poly/Mount
(Polysciences). Images were acquired with a Nikon Eclipse E800 fluorescence
deconvolution microscope.
Live cell imaging. Live cell imaging was performed as described previously27.
Chromosome analysis. Chromosome analysis of cells in metaphase was per-
formed as described23.
In vitro ubiquitination/degradation assay.HA-tagged wild-type REST or HA-
tagged REST(E1009/S1013A) were immunoprecipitated with anti-HA antibody
fromHeLa cells infected with lentiviruses expressingHA-tagged wild-type REST
or HA-tagged REST(E1009/S1013A), treated with nocodazole for 15 h and
with MG132 for the last 3 h. Immunoprecipitates were incubated with either l
phosphatase or phosphatase buffer for 1 h at 30 uC. In vitro ubiquitination/
degradation assays were performed by adding to agarose beads 10ml containing
50mM Tris-HCl pH7.6, 5mM MgCl2, 0.6mM dithiothreitol, 2mM ATP,
1.5 ng ml21 E1 (Boston Biochem), 10 ng ml21 Ubc3, 10 ng ml21 Ubc5, 2.5mgml21
ubiquitin (Sigma), 1mM ubiquitin aldehyde and 2 ml of unlabelled in vitro
transcribed/translated b-TrCP1 or FBXW8. The reactions were then incubated
at 30 uC for the indicated durations and analysed by immunoblotting with an
anti-HA antibody.
Interactionmodels.All-atommodels of all peptides were derived from the PDB
structure of b-TrCP bound to b-catenin (PDB: 1p22) using a stochastic global
optimization in internal coordinates with pseudo-brownian and collective
probability-biased random moves as implemented in the ICM 3.0 program
(Molsoft; ICM software manual, Version 3.0, 2004). The energy function used
to calculate the interaction energy of phosphoserine andmutations with b-TrCP
uses ECEPP/3 force-field parameters31:
E5 Eel1 Ehb
in which Ehb is an original ECEPP/3 energy function. The electrostatics term Eel
was calculated by using the boundary element method with ECEPP/3 atomic
charges and an internal dielectric constant of 4.0 (ref. 32). The same energy
function was used to assess 54 crystallographically resolved phosphoserines con-
taining only one contacting arginine and bound at protein interaction sites from
the Protein Data Bank. The mean and one standard deviation of the range of
energy values is shown by the vertical green line in Supplementary Fig. 3.
31. Nemethy, G. et al. Energy parameters in polypeptides. 10. Improved geometric
parameters and nonbonded interactions for use in the ECEPP/3 algorithm
with application to proline-containing peptides. J. Phys. Chem. 96, 6472–6484
(1992).
32. Totrov, M. & Abagyan, R. Rapid boundary element solvation electrostatics
calculations in folding simulations: successful folding of a 23-residue peptide.
Biopolymers 60, 124–133 (2001).
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